Cergutuzumab amunaleukin
Product Specifications
CAS Number
1509916-03-3
Target
Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.997
Bioactivity
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with immunostimulatory and anti-tumor activities for the study of solid cancers.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6452345-01 0.1 mL
FBG5 (F Box 5, FBG-5, FBG 5, F-box G-domain Protein 5, F-box Only Protein 27, FBXO27, F-box Protein 27, FBX27) (AP)
Sign In for Pricing
View Details MBS6452345-02 5x 0.1 mL
FBG5 (F Box 5, FBG-5, FBG 5, F-box G-domain Protein 5, F-box Only Protein 27, FBXO27, F-box Protein 27, FBX27) (AP)
Sign In for Pricing
View Details 
MBS1160029-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 Exodeoxyribonuclease 7 large subunit (xseA)
Sign In for Pricing
View Details